糖尿病合并晚期肾病患者的移植选择:综述
本综述讨论糖尿病需胰岛素治疗且适合肾移植的慢性肾脏病患者的移植选项,包括胰腺或胰岛移植的β细胞替代治疗。早期转诊(eGFR<30 mL/min/1.73 m2)对充分决策和移植前评估至关重要,需处理肥胖、心血管疾病等状况。
要点
- 糖尿病肾移植受者最佳血糖控制与改善患病率和移植物存活相关。
- 适合肾移植的糖尿病需胰岛素治疗患者应考虑胰腺或胰岛移植。
- 早期转诊(eGFR<30 mL/min/1.73 m2)确保充分决策和移植前评估。
核心结论
- 糖尿病需胰岛素治疗的晚期肾病患者若适合肾移植,应考虑β细胞替代治疗(胰腺或胰岛移植)。
研究设计与样本
- 综述,未报告检索范围与样本量。
主要发现
- 肾移植受者最佳血糖控制与改善患病率和患者及移植物存活相关。
- 提供胰腺或胰岛移植选项存在国际法规政策差异,并受分配政策和等待名单动态影响。
- 合适候选者的选择取决于年龄、共存疾病、转诊时机(透析前或透析中)和活体肾供者可用性。
关键数值与推荐
- 早期转诊指估计肾小球滤过率<30 mL/min/1.73 m2。
- 肥胖、心血管疾病、外周血管疾病、吸烟和衰弱是移植名单接受前需处理的状况。
临床怎么用
- 转诊肾内科医生应早期转诊(eGFR<30 mL/min/1.73 m2)以留出充分决策和移植前评估时间。
- 在透析即将开始前处理肥胖、心血管疾病、外周血管疾病、吸烟和衰弱等状况。
局限性
- 综述未报告系统检索范围与纳入研究数量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Optimal glycemic control in kidney transplant recipients with diabetes is associated with improved morbidity and better patient and allograft survival. Transplant options for patients with diabetes requiring insulin therapy and chronic kidney disease who are suitable candidates for kidney transplantation should include consideration of β-cell replacement therapy: pancreas or islet transplantation. International variation related to national regulatory policies exists in offering one or both options to suitable candidates and is further affected by pancreas/islet allocation policies and transplant waiting list dynamics. The selection of appropriate candidates depends on patient age, coexistent morbidities, the timing of referral to the transplant center (predialysis versus on dialysis) and availability of living kidney donors. Therefore, early referral (estimated glomerular filtration rate < 30 mL/min/1.73 m2) is of the utmost importance to ensure adequate time for informed decision making and thorough pretransplant evaluation. Obesity, cardiovascular disease, peripheral vascular disease, smoking, and frailty are some of the conditions that need to be addressed before acceptance on the transplant list, and ideally before dialysis becoming imminent. This review offers insights into selection of pancreas/islet transplant candidates by transplant centers and an update on posttransplant outcomes, which may have practice implications for referring nephrologists.
引用
- Kukla A, Ventura-Aguiar P, Cooper M, et al. Transplant Options for Patients With Diabetes and Advanced Kidney Disease: A Review. Am J Kidney Dis. 2021. PMID: 33992729. doi:10.1053/j.ajkd.2021.02.339
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。